Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of phenotyping and replication capacity in anti-HIV therapeutics.

Current opinion in molecular therapeutics - 1 Jun 2004

Baliga Christopher S, Sutton Richard E

Abstract excerpt

The management of antiretroviral-experienced and -naive HIV-infected patients is becoming increasingly complex with the emergence of multidrug-resistant viruses and with the inter-relationships between numerous virological, immunological and therapeutic factors. In addition to standard surrogate markers of peripheral CD4+ T-cell counts and plasma viral loads, viral resistance phenotype, replication capacity and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Drug Resistance, Viral

Share to HIV Seropositivity

Share to Viral Load

Share to Virus Replication

Source

Identifiers

PMID: 15264434

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of phenotyping and replication capacity in anti-HIV therapeutics.PMID 15264434Read ↗

Resistance and replication capacity assays: clinical utility and interpretation.Semantic proximity Read ↗

Antiretroviral resistance testing for clinical management.Semantic proximity Read ↗

HIV drug resistance: genotypic assays and their possible applications.Semantic proximity Read ↗

HIV resistance testing: methods, utility, and limitations.Semantic proximity Read ↗

Genotype and phenotype resistance: an overview.Semantic proximity Read ↗

HIV-1 drug resistance assays in clinical management.Semantic proximity Read ↗

Development and performance of conventional HIV-1 phenotyping (Antivirogram®) and genotype-based calculated phenotyping assay (virco®TYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistance.Semantic proximity Read ↗

HIV Genetic Diversity and Drug ResistanceSemantic proximity Read ↗

Update on antiretroviral drug resistance testing: combining laboratory technology with patient care.Semantic proximity Read ↗

Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure.Semantic proximity Read ↗

Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 1).Semantic proximity Read ↗

Antiretroviral resistance in clinical practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.